Phase I bioequivalence trial of aspirin/omeprazole to enteric-coated aspirin 325mg using acetylsalicylic acid as the analyte.
Phase of Trial: Phase I
Latest Information Update: 16 Jul 2014
At a glance
- Drugs Aspirin/omeprazole (Primary) ; Aspirin
- Indications Cardiovascular disorders; NSAID-induced ulcer; Thrombosis
- Focus Pharmacokinetics; Registrational
- 25 Jun 2012 New trial record
- 01 May 2012 POZEN has completed a phase I bioequivalence trial.